Izšla je devetnajsta številka revije POSTANI Fit

Revija PostaniFit

 
Maxximum Pure Whey okus jabolko/cimet 50% ceneje Sukrin + GRATIS Almitas maslo iz bučnih semen
 
Danes je Po jun 18, 2018 20:30

Keto/Low carb študije

Moderatorji: UrosS, Metka, Stasa, Grom

<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr okt 18, 2017 15:40

Re: Keto/Low carb študije

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model

Neuroblastoma (NB) is a pediatric malignancy characterized by a marked reduction in aerobic energy metabolism. Recent preclinical data indicate that targeting this metabolic phenotype by a ketogenic diet (KD), especially in combination with calorie restriction, slows tumor growth and enhances metronomic cyclophosphamide (CP) therapy of NB xenografts. Because calorie restriction would be contraindicated in most cancer patients, the aim of the present study was to optimize the KD such that the tumors are sensitized to CP without the need of calorie restriction. In a NB xenograft model, metronomic CP was combined with KDs of different triglyceride compositions and fed to CD1-nu mice ad libitum. Metronomic CP in combination with a KD containing 8-carbon medium-chain triglycerides exerted a robust anti-tumor effect, suppressing growth and causing a significant reduction of tumor blood-vessel density and intratumoral hemorrhage, accompanied by activation of AMP-activated protein kinase in NB cells. Furthermore, the KDs caused a significant reduction in the serum levels of essential amino acids, but increased those of serine, glutamine and glycine. Our data suggest that targeting energy metabolism by a modified KD may be considered as part of a multimodal treatment regimen to improve the efficacy of classic anti-NB therapy.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr okt 18, 2017 15:41

Re: Keto/Low carb študije

Ketogenic metabolism inhibits histone deacetylase (HDAC) and reduces oxidative stress after spinal cord injury in rat

Ketogenic metabolism inhibited HDAC activity and increased histone acetylation in spinal cord tissue in rats.
Ketogenic metabolism increased the expression of oxidative stress resistance gene Foxo3a and Mt2 in rat spinal cord.
The changes in histone acetylation and gene expression caused by Ketogenic metabolism may contribute to oxidative stress resistance after acute SCI.
The anti-oxidative stress capacity of three ketogenic metabolism groups seemed to be βOHB dose-dependent.

Abstract

The aim of this study is to investigate the effect of ketogenic metabolism, induced by different diet interventions, on histone acetylation and its potential antioxidant capacity to injured spinal cord tissue in rats. 72 male Sprague–Dawley rats were randomly divided into 4 groups, fed with ketogenic diet (KD), every other day fasting (EODF), every other day ketogenic diet (EODKD) and standard diet (SD) respectively for 2 weeks. β-Hydroxybutyrate (βOHB) concentration was measured both in serum and cerebrospinal fluid (CSF). C5 spinal cord tissue was harvested before, at 3 h and 24 h after injury for analysis of HDAC activity, histone acetylation and oxidative makers. All three dietary interventions resulted in a significant increase of βOHB level in both serum and CSF, and inhibited HDAC activity by 31–43% in spinal cord. Moreover, the expressions of acetylated histone AcH3K9 and AcH3K14 were significantly increased. Anti-oxidative stress genes Foxo3a and Mt2 and related proteins, such as Mitochondrial superoxide dismutase (SOD), FOXO3a, catalase were increased in dietary intervention groups. After SCI, high ketogenic metabolism demonstrated significant reduction of the expression of lipid peroxidation factors malondialdehyde (MDA), and this might contribute to the reported neuroprotection of the spinal cord from oxidative damage possibly mediated by increasing SOD. The result of this study suggested that by inhibiting HDAC activity and modifying related gene transcription, ketogenic metabolism, induced by KD, EODF or EODKD, might reduce oxidative damage in spinal cord tissue after acute injury.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr okt 18, 2017 15:43

Re: Keto/Low carb študije

Ketone Body Acetoacetate Buffers Methylglyoxal via a Non-enzymatic Conversion during Diabetic and Dietary Ketosis

In vivo reaction between MG and AcAcO yields the novel metabolite 3-HHD
The rate of reaction matches that of known pharmacological scavengers of MG
A metabolite-alkyne-tagging strategy clarifies the reductive metabolism of 3-HHD
MG-scavenging expands the known biological functions of ketone bodies

Summary

The α-oxoaldehyde methylglyoxal is a ubiquitous and highly reactive metabolite known to be involved in aging- and diabetes-related diseases. If not detoxified by the endogenous glyoxalase system, it exerts its detrimental effects primarily by reacting with biopolymers such as DNA and proteins. We now demonstrate that during ketosis, another metabolic route is operative via direct non-enzymatic aldol reaction between methylglyoxal and the ketone body acetoacetate, leading to 3-hydroxyhexane-2,5-dione. This novel metabolite is present at a concentration of 10%–20% of the methylglyoxal level in the blood of insulin-starved patients. By employing a metabolite-alkyne-tagging strategy it is clarified that 3-hydroxyhexane-2,5-dione is further metabolized to non-glycating species in human blood. The discovery represents a new direction within non-enzymatic metabolism and within the use of alkyne-tagging for metabolism studies and it revitalizes acetoacetate as a competent endogenous carbon nucleophile.
Introduction

The elucidation of the major pathways of intermediary metabolism during the 1930s and 1940s constitutes one of the golden eras of twentieth-century biochemical research. Convergence toward the now canonical catabolic and anabolic processes, such as glycolysis, the tricarboxylic acid cycle and the β-oxidation pathways was, however, side-tracked in several instances by alternative hypotheses. One of the more spectacular involved a putative link between the metabolism of fatty acids and carbohydrates, reported in the 1930s by Henze and co-workers. This hypothesis arose from the observation that a product of fatty acid catabolism, acetoacetate (AcAcO), under preparative conditions undergoes a chemical reaction with the 3-carbon α-oxoaldehyde methylglyoxal (MG) (Henze, 1930, Henze and Müller, 1930). The latter was at the time speculated as being a pivotal intermediate of glycolysis (Neuberg and Kerb, 1914). The product of this reaction, 3-hydroxyhexane-2,5-dione (3-HHD 1) (Figure 1), appeared to be labile toward chemical oxidations, eventually breaking down to pyruvate (Henze, 1930) and thus providing an exciting metabolic possibility for converting fatty acids into carbohydrates (Stöhr and Henze, 1932). However, the subsequent discovery of the phosphorylated intermediates of glycolysis (Embden et al., 1933) put an end to the so-called “methylglyoxal hypothesis” and the hypothetical 3-HHD-forming reaction was forgotten. MG, in fact, is a glycolytic side product generated by spontaneous elimination of phosphate from triosephosphates and through non-enzymatic conversion of sugars, amino acids, and even ketone bodies (Maessen et al., 2015, Matafome et al., 2013, Milligan and Baldwin, 1967, Thornalley, 1996). Despite the evolution of efficient enzymatic detoxification systems (glyoxalase I and II) that are ubiquitous throughout the kingdoms of life (Thornalley, 1996), and despite the very low endogenous levels of MG, e.g., in plasma (140 nM [normal] to 340 nM [diabetic ketosis]) (Lu et al., 2011), MG is a source of biological damage through its ability to chemically modify proteinogenic lysine and arginine residues as well as nucleic acids resulting in a series of advanced glycation end products (AGEs) (Thornalley, 1996). MG and associated AGEs are linked to several aging-related pathologies (Maessen et al., 2015) and elevated levels of MG present in diabetic patients mediate various complications associated with this disease (Bierhaus et al., 2012, Brownlee, 2005, McLellan et al., 1994, Thornalley, 1996). Our understanding of the biology of non-enzymatic post-translational modifications (PTMs) is likely quite rudimentary, notwithstanding the high importance of such processes as demonstrated by a number of recent studies (Baeza et al., 2015, Moellering and Cravatt, 2013, Wang et al., 2014). For instance, the discovery of a non-enzymatic regulatory mechanism within the glycolytic pathway (Moellering and Cravatt, 2013) is a finding that demonstrates that even the most extensively studied cellular pathways may hold additional complexity. In comparison with non-enzymatic PTMs, the non-enzymatic metabolome is an even less-explored frontier of biology (Keller et al., 2015). Although 3-HHD initially turned out being a metabolic mirage, the co-occurrence of elevated concentrations of both MG and AcAcO during diabetic ketosis (Lu et al., 2011) suggested to us that 3-HHD might indeed be formed under such pathophysiological conditions.

In this article we provide the first evidence for the presence of 3-HHD in the blood of ketotic individuals, and demonstrate that the reaction of AcAcO with MG kinetically can compete with known pharmacological scavengers of MG. Furthermore, using a novel metabolite-tagging strategy, we show that 3-HHD primarily undergoes reductive metabolism to non-glycating species in human blood, although 3-HHD is also capable of modifying proteins.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr okt 18, 2017 15:45

Re: Keto/Low carb študije

Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice


Feeding isoprotein ketogenic diet to mice every other week (Cyclic KD) avoids obesity
Cyclic KD reduces midlife mortality with no change in maximum lifespan
Cyclic KD prevents memory decline with modest other healthspan effects
Gene expression of KD is similar to high-fat diet, except for activation of PPARα targets

Summary

Ketogenic diets recapitulate certain metabolic aspects of dietary restriction such as reliance on fatty acid metabolism and production of ketone bodies. We investigated whether an isoprotein ketogenic diet (KD) might, like dietary restriction, affect longevity and healthspan in C57BL/6 male mice. We find that Cyclic KD, KD alternated weekly with the Control diet to prevent obesity, reduces midlife mortality but does not affect maximum lifespan. A non-ketogenic high-fat diet (HF) fed similarly may have an intermediate effect on mortality. Cyclic KD improves memory performance in old age, while modestly improving composite healthspan measures. Gene expression analysis identifies downregulation of insulin, protein synthesis, and fatty acid synthesis pathways as mechanisms common to KD and HF. However, upregulation of PPARα target genes is unique to KD, consistent across tissues, and preserved in old age. In all, we show that a non-obesogenic ketogenic diet improves survival, memory, and healthspan in aging mice.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Po nov 06, 2017 18:14

Re: Keto/Low carb študije

Keto-adaptation enhances exercise performance and body composition responses to training in endurance athletes
Fionn T. McSwiney
, Bruce Wardrop
, Parker N. Hyde
, Richard A. Lafountain
, Jeff S. Volek


Abstract
Background

Low-carbohydrate diets have recently grown in popularity among endurance athletes, yet little is known about the long-term (>4 wk) performance implications of consuming a low-carbohydrate high fat ketogenic diet (LCKD) in well-trained athletes.
Methods

Twenty male endurance-trained athletes (age 33 ± 11y, body mass 80 ± 11kg; BMI 24.7 ± 3.1 kg/m2) who habitually consumed a carbohydrate-based diet, self-selected into a high-carbohydrate (HC) group (n = 11, %carbohydrate:protein:fat = 65:14:20), or a LCKD group (n = 9, 6:17:77). Both groups performed the same training intervention (endurance, strength and high intensity interval training (HIIT)). Prior to and following successful completion of 12-weeks of diet and training, participants had their body composition assessed, and completed a 100km time trial (TT), six second (SS) sprint, and a critical power test (CPT). During post-intervention testing the HC group consumed 30–60g/h carbohydrate, whereas the LCKD group consumed water, and electrolytes.
Results

The LCKD group experienced a significantly greater decrease in body mass (HC -0.8 kg, LCKD -5.9 kg; P = 0.009, effect size (ES): 0.338) and percentage body fat percentage (HC -0.7%, LCKD -5.2%; P = 0.008, ES: 0.346). Fasting serum beta-hydroxybutyrate (βHB) significantly increased from 0.1 at baseline to 0.5 mmol/L in the LCKD group (P = 0.011, ES: 0.403) in week 12. There was no significant change in performance of the 100 km TT between groups (HC -1.13 min.sec, LCKD -4.07 min.sec, P = 0.057, ES: 0.196). SS sprint peak power increased by 0.8 watts per kilogram bodyweight (w/kg) in the LCKD group, versus a -0.1 w/kg reduction in the HC group (P = 0.025, ES: 0.263). CPT peak power decreased by -0.7w/kg in the HC group, and increased by 1.4 w/kg in the LCKD group (P = 0.047, ES: 0.212). Fat oxidation in the LCKD group was significantly greater throughout the 100km TT.
Conclusions

Compared to a HC comparison group, a 12-week period of keto-adaptation and exercise training, enhanced body composition, fat oxidation during exercise, and specific measures of performance relevant to competitive endurance athletes.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Po nov 06, 2017 18:32

Re: Keto/Low carb študije

A Ketone Ester Drink Lowers Human Ghrelin and Appetite


Author contributions: BJS, KC, and PJC designed the research studies. BJS, PJC, HdW and RDE carried out the studies. BJS, HdW, and MC analyzed the data. BJS wrote the paper with help from MC, HdW, and KC. HdW had primary responsibility for the final content. All authors read and approved the final manuscript.

Clinical trial registration: Research Ethics Committee (NHS Queen's Square 14/LO/0288), www.hra.nhs.uk.

Abstract
Objective

The ketones d-β-hydroxybutyrate (BHB) and acetoacetate are elevated during prolonged fasting or during a “ketogenic” diet. Although weight loss on a ketogenic diet may be associated with decreased appetite and altered gut hormone levels, it is unknown whether such changes are caused by elevated blood ketones. This study investigated the effects of an exogenous ketone ester (KE) on appetite.
Methods

Following an overnight fast, subjects with normal weight (n = 15) consumed 1.9 kcal/kg of KE, or isocaloric dextrose (DEXT), in drinks matched for volume, taste, tonicity, and color. Blood samples were analyzed for BHB, glucose, insulin, ghrelin, glucagon-like peptide 1 (GLP-1), and peptide tyrosine tyrosine (PYY), and a three-measure visual analogue scale was used to measure hunger, fullness, and desire to eat.
Results

KE consumption increased blood BHB levels from 0.2 to 3.3 mM after 60 minutes. DEXT consumption increased plasma glucose levels between 30 and 60 minutes. Postprandial plasma insulin, ghrelin, GLP-1, and PYY levels were significantly lower 2 to 4 hours after KE consumption, compared with DEXT consumption. Temporally related to the observed suppression of ghrelin, reported hunger and desire to eat were also significantly suppressed 1.5 hours after consumption of KE, compared with consumption of DEXT.
Conclusions

Increased blood ketone levels may directly suppress appetite, as KE drinks lowered plasma ghrelin levels, perceived hunger, and desire to eat.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Po nov 13, 2017 22:00

Re: Keto/Low carb študije

Epigenetic mechanisms underlying lifespan and age-related effects of dietary restriction and the ketogenic diet.
Moreno CL1, Mobbs CV2.
Author information
Abstract

Aging constitutes the central risk factor for major diseases including many forms of cancer, neurodegeneration, and cardiovascular diseases. The aging process is characterized by both global and tissue-specific changes in gene expression across taxonomically diverse species. While aging has historically been thought to entail cell-autonomous, even stochastic changes, recent evidence suggests that modulation of this process can be hierarchal, wherein manipulations of nutrient-sensing neurons (e.g., in the hypothalamus) produce peripheral effects that may modulate the aging process itself. The most robust intervention extending lifespan, plausibly impinging on the aging process, involves different modalities of dietary restriction (DR). Lifespan extension by DR is associated with broad protection against diseases (natural and engineered). Here we review potential epigenetic processes that may link lifespan to age-related diseases, particularly in the context of DR and (other) ketogenic diets, focusing on brain and hypothalamic mechanisms.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor To nov 14, 2017 15:40

Re: Keto/Low carb študije

10 patients, 10 years – long term follow-up of cardiovascular risk factors in Glut1 Deficiency treated with ketogenic diet therapies: a prospective, multicenter case series

Highlights

•Long-term follow-up on cardiovascular risk of ketogenic diets refutes prior reports.
•To evaluate cardiovascular risks an at least 5 year follow-up is mandatory.
•Initial dyslipidaemia resolves over time and remains normal at 10 years.
•Carotid intima-media thickness does not increase during long-term application.
•Ketogenic diets are still the treatment of choice for Glut1 Deficiency.

Abstract
Background and Aims

Glut1 Deficiency (Glut1D) is caused by impaired glucose transport into brain. The resulting epileptic encephalopathy and movement disorders can be treated effectively by high-fat carbohydrate-restricted ketogenic diets (KDT) mimicking fasting and providing ketones as an alternative cerebral fuel. Recently 6-24 months follow-ups of epileptic patients reported elevated blood lipids and intima thickening of the carotid artery raising concerns about potential cardiovascular risks by KDTs. To further clarify potential cardiovascular risks on ketogenic diets therapy.
Methods

Between August 2001 and January 2008 we enrolled Glut1D patients on KDT at two hospitals in Germany in this prospective, multicenter case series. The minimal follow up was 10 years. Standard deviation scores (SDS) of body mass index (BMI), total cholesterol (TC), HDL-/LDL cholesterol and triglycerides (TG) before initiation of KDT were compared with the respective values at 6 months, 2, 5 years and 10 years after initiation. After 10 years on KDT cardiovascular risk, assessed by BMI, carotid intima-media thickness (CIMT) measurement and blood pressure, was compared to a healthy reference population (n=550).
Results

Baseline and 10 year follow-up investigations were available from 10 individuals with Glut1D on KDT. After two years on KDT BMI increased significantly, while total cholesterol, HDL-cholesterol, and LDL-cholesterol decreased. Within 3-5 years on KDT these differences disappeared, and after 10 years blood lipid parameters reflected the situation at initiation of KDT. Before initiation of KDT one child had dyslipidaemia, but no child after 10 years. No significant differences were observed with respect to BMI SDS (p=0.26), CIMT (p=0.63) or systolic and diastolic blood pressure SDS (p=0.11 and p=0.37, respectively) in Glut1D children treated with KDT for ≥ 10 years compared to healthy controls.
Conclusions

In contrast to previous short-term reports on adverse effects of KDTs, 10-year follow-up did not identify cardiovascular risks of dietary treatment for Glut1D.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor To nov 14, 2017 16:08

Re: Keto/Low carb študije

Ketone body 3-hydroxybutyrate mimics calorie restriction via the Nrf2 activator, fumarate, in the retina


Summary

Calorie restriction (CR) being the most robust dietary intervention provides various health benefits. D-3-hydroxybutyrate (3HB), a major physiological ketone, has been proposed as an important endogenous molecule for CR. To investigate the role of 3HB in CR, we investigated potential shared mechanisms underlying increased retinal 3HB induced by CR and exogenously applied 3HB without CR to protect against ischemic retinal degeneration. The repeated elevation of retinal 3HB, with or without CR, suppressed retinal degeneration. Metabolomic analysis showed that the antioxidant pentose phosphate pathway and its limiting enzyme, glucose-6-phosphate dehydrogenase (G6PD), were concomitantly preserved. Importantly, the upregulation of nuclear factor erythroid 2 p45-related factor 2 (Nrf2), a regulator of G6PD, and elevation of the tricarboxylic acid cycle's Nrf2 activator, fumarate, were also shared. Together, our findings suggest that CR provides retinal antioxidative defense by 3HB through the antioxidant Nrf2 pathway via modification of a tricarboxylic acid cycle intermediate during 3HB metabolism.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Pe nov 24, 2017 19:28

Re: Keto/Low carb študije

Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?
Marwa Elamin1, David N. Ruskin2, Susan A. Masino2* and Paola Sacchetti1*


The ketogenic diet’s (KD) anticonvulsant effects have been well-documented for nearly a century, including in randomized controlled trials. Some patients become seizure-free and some remain so after diet cessation. Many recent studies have explored its expanded therapeutic potential in diverse neurological disorders, yet no mechanism(s) of action have been established. The diet’s high fat, low carbohydrate composition reduces glucose utilization and promotes the production of ketone bodies. Ketone bodies are a more efficient energy source than glucose and improve mitochondrial function and biogenesis. Cellular energy production depends on the metabolic coenzyme nicotinamide adenine dinucleotide (NAD), a marker for mitochondrial and cellular health. Furthermore, NAD activates downstream signaling pathways (such as the sirtuin enzymes) associated with major benefits such as longevity and reduced inflammation; thus, increasing NAD is a coveted therapeutic endpoint. Based on differential NAD+ utilization during glucose- vs. ketone body-based acetyl-CoA generation for entry into the tricarboxylic cycle, we propose that a KD will increase the NAD+/NADH ratio. When rats were fed ad libitum KD, significant increases in hippocampal NAD+/NADH ratio and blood ketone bodies were detected already at 2 days and remained elevated at 3 weeks, indicating an early and persistent metabolic shift. Based on diverse published literature and these initial data we suggest that increased NAD during ketolytic metabolism may be a primary mechanism behind the beneficial effects of this metabolic therapy in a variety of brain disorders and in promoting health and longevity.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Če dec 07, 2017 10:15

Re: Keto/Low carb študije

Induced and controlled dietary ketosis as a regulator of obesity and metabolic syndrome pathologies


Abstract

A worsening epidemic of diabetes and its precursor, metabolic syndrome (MetS) is engulfing America. A healthy individual, with proper glucose regulation has an ability to switch between burning fat and carbohydrates. It has been suggested that signaling errors within this homeostatic system, characterized by impaired switching of substrate oxidation from glucose to fat in response to insulin, can contribute to the etiology of metabolic syndrome and occurs before the development of type II diabetes.

Glucose regulation with restored insulin sensitivity facilitated through clinically regulated, benign dietary ketosis (BDK), may significantly reduce, regulate and reverse the adverse pathologies common to MetS and obesity. The study assessed if prolonged maintenance of induced and controlled physiological, dietary ketosis, would reverse pathological processes induced by MetS including a reduction in fasting triglycerides, BMI (body mass index) and body fat mass (BFM), weight, a significant decrease and/or normalization of hemoglobin A1c (HgA1c) and an increase in resting metabolic rate (RMR) and blood ketones. A group of 30 adults, previously diagnosed with MetS by their primary care physician, were randomly prescribed to one of three groups: a sustained ketogenic diet with no exercise, standard American diet (SAD) with no exercise or SAD with 3-5 days per week of exercise (30 min.). The results demonstrated that the change over time from week 0 to week 10 was significant (p = 0.001) in the ketogenic group for weight, body fat percentage, BMI, HgA1c and ketones. All variables for the ketogenic group out-performed those of the exercise and non-exercise groups, with five of the seven demonstrating statistical significance.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Ne dec 10, 2017 07:05

Re: Keto/Low carb študije

Carbohydrate-Restriction with High-Intensity Interval Training: An Optimal Combination for Treating Metabolic Diseases?


Lifestyle interventions incorporating both diet and exercise strategies remain cornerstone therapies for treating metabolic disease. Carbohydrate-restriction and high-intensity interval training (HIIT) have independently been shown to improve cardiovascular and metabolic health. Carbohydrate-restriction reduces postprandial hyperglycemia, thereby limiting potential deleterious metabolic and cardiovascular consequences of excessive glucose excursions. Additionally, carbohydrate-restriction has been shown to improve body composition and blood lipids. The benefits of exercise for improving insulin sensitivity are well known. In this regard, HIIT has been shown to rapidly improve glucose control, endothelial function, and cardiorespiratory fitness. Here, we report the available evidence for each strategy and speculate that the combination of carbohydrate-restriction and HIIT will synergistically maximize the benefits of both approaches. We hypothesize that this lifestyle strategy represents an optimal intervention to treat metabolic disease; however, further research is warranted in order to harness the potential benefits of carbohydrate-restriction and HIIT for improving cardiometabolic health.

Conclusion: HIIT with Carbohydrate-Restriction: an Optimal Combination for Individuals with T2D?

We hypothesize that the combination of HIIT with a carbohydrate-restrictive diet may be the most effective strategy to reduce hyperglycemia, improve insulin sensitivity, promote favorable changes in body composition, and preserve (or increase) endothelial function in patients with T2D. While the combination of diet and exercise for the treatment of T2D is self-evident, the optimal combination is yet to be determined. Strategically timing HIIT in proximity to low-carbohydrate high-fat meals may synergistically maximize the benefits of both approaches, as well as minimize any potential negative effects of postprandial lipemia if one is following a low-carbohydrate high-fat diet. Such a strategy is indeed testable and warranted to improve cardiometabolic health and reduce cardiovascular risk in T2D.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Ne dec 10, 2017 07:07

Re: Keto/Low carb študije

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
Matthew K. Taylor, Debra K. Sullivan, Jonathan D. Mahnken, Jeffrey M. Burns, Russell H. Swerdlow


•The medium-chain triglyceride–supplemented KD was feasible in very mild (clinical dementia rating [CDR] 0.5) and mild (CDR 1) Alzheimer's disease participants, as 10 of 11 participants adhered to the dietary protocol.
•The medium chain triglyceride-supplemented KD was not feasible in moderate (CDR 2) Alzheimer's disease participants as all four of these participants withdrew from the study.
•Dietary compliant participants had a 4.1-point mean improvement on Alzheimer's Disease Assessment Scale-cognitive subscale scores from baseline to the end of the diet. Alzheimer's Disease Assessment Scale-cognitive subscale improvements diminished after a 1-month diet washout period.

Abstract

Introduction
We assessed the feasibility and cognitive effects of a ketogenic diet (KD) in participants with Alzheimer's disease.
Methods
The Ketogenic Diet Retention and Feasibility Trial featured a 3-month, medium-chain triglyceride–supplemented KD followed by a 1-month washout in clinical dementia rating (CDR) 0.5, 1, and 2 participants. We obtained urine acetoacetate, serum β-hydroxybutyrate, food record, and safety data. We administered the Alzheimer's Disease Assessment Scale-cognitive subscale and Mini–Mental State Examination before the KD, and following the intervention and washout.
Results
We enrolled seven CDR 0.5, four CDR 1, and four CDR 2 participants. One CDR 0.5 and all CDR 2 participants withdrew citing caregiver burden. The 10 completers achieved ketosis. Most adverse events were of medium-chain triglyceride–related. Among the completers, the mean of the Alzheimer's Disease Assessment Scale-cognitive subscale score improved by 4.1 points during the diet (P = .02) and reverted to baseline after the washout.
Conclusion
This pilot trial justifies KD studies in mild Alzheimer's disease.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr dec 13, 2017 16:49

Re: Keto/Low carb študije

Gluconeogenesis during endurance exercise in cyclists habituated to a long-term low carbohydrate high-fat diet.
Webster CC1, Noakes TD1, Chacko SK2, Swart J1, Kohn TA1, Smith JA1.
Author information
Abstract
KEY POINTS:

Blood glucose is an important fuel for endurance exercise. It can be derived from ingested carbohydrate, stored liver glycogen and newly synthesized glucose (gluconeogenesis). We hypothesized that athletes habitually following a low carbohydrate high fat (LCHF) diet would have higher rates of gluconeogenesis during exercise compared to those who follow a mixed macronutrient diet. We used stable isotope tracers to study glucose production kinetics during a 2 h ride in cyclists habituated to either a LCHF or mixed macronutrient diet. The LCHF cyclists had lower rates of total glucose production and hepatic glycogenolysis but similar rates of gluconeogenesis compared to those on the mixed diet. The LCHF cyclists did not compensate for reduced dietary carbohydrate availability by increasing glucose synthesis during exercise but rather adapted by altering whole body substrate utilization.
ABSTRACT:

Endogenous glucose production (EGP) occurs via hepatic glycogenolysis (GLY) and gluconeogenesis (GNG) and plays an important role in maintaining euglycaemia. Rates of GLY and GNG increase during exercise in athletes following a mixed macronutrient diet; however, these processes have not been investigated in athletes following a low carbohydrate high fat (LCHF) diet. Therefore, we studied seven well-trained male cyclists that were habituated to either a LCHF (7% carbohydrate, 72% fat, 21% protein) or a mixed diet (51% carbohydrate, 33% fat, 16% protein) for longer than 8 months. After an overnight fast, participants performed a 2 h laboratory ride at 72% of maximal oxygen consumption. Glucose kinetics were measured at rest and during the final 30 min of exercise by infusion of [6,6-(2) H2 ]-glucose and the ingestion of (2) H2 O tracers. Rates of EGP and GLY both at rest and during exercise were significantly lower in the LCHF group than the mixed diet group (Exercise EGP: LCHF, 6.0 ± 0.9 mg kg(-1) min(-1) , Mixed, 7.8 ± 1.1 mg kg(-1) min(-1) , P < 0.01; Exercise GLY: LCHF, 3.2 ± 0.7 mg kg(-1) min(-1) , Mixed, 5.3 ± 0.9 mg kg(-1) min(-1) , P < 0.01). Conversely, no difference was detected in rates of GNG between groups at rest or during exercise (Exercise: LCHF, 2.8 ± 0.4 mg kg(-1) min(-1) , Mixed, 2.5 ± 0.3 mg kg(-1) min(-1) , P = 0.15). We conclude that athletes on a LCHF diet do not compensate for reduced glucose availability via higher rates of glucose synthesis compared to athletes on a mixed diet. Instead, GNG remains relatively stable, whereas glucose oxidation and GLY are influenced by dietary factors.
Vabljeni na moje spletne strani: www.gaspergrom.com
<< x

Grom

Uporabniški avatar

Šefe

Vnosov: 62853

Pridružen: Če sep 23, 2004 18:35

Odgovor Sr dec 20, 2017 08:30

Re: Keto/Low carb študije

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease



Highlights

The medium-chain triglyceride–supplemented KD was feasible in very mild (clinical dementia rating [CDR] 0.5) and mild (CDR 1) Alzheimer's disease participants, as 10 of 11 participants adhered to the dietary protocol.

The medium chain triglyceride-supplemented KD was not feasible in moderate (CDR 2) Alzheimer's disease participants as all four of these participants withdrew from the study.

Dietary compliant participants had a 4.1-point mean improvement on Alzheimer's Disease Assessment Scale-cognitive subscale scores from baseline to the end of the diet. Alzheimer's Disease Assessment Scale-cognitive subscale improvements diminished after a 1-month diet washout period.

Abstract
Introduction

We assessed the feasibility and cognitive effects of a ketogenic diet (KD) in participants with Alzheimer's disease.
Methods

The Ketogenic Diet Retention and Feasibility Trial featured a 3-month, medium-chain triglyceride–supplemented KD followed by a 1-month washout in clinical dementia rating (CDR) 0.5, 1, and 2 participants. We obtained urine acetoacetate, serum β-hydroxybutyrate, food record, and safety data. We administered the Alzheimer's Disease Assessment Scale-cognitive subscale and Mini–Mental State Examination before the KD, and following the intervention and washout.
Results

We enrolled seven CDR 0.5, four CDR 1, and four CDR 2 participants. One CDR 0.5 and all CDR 2 participants withdrew citing caregiver burden. The 10 completers achieved ketosis. Most adverse events were of medium-chain triglyceride–related. Among the completers, the mean of the Alzheimer's Disease Assessment Scale-cognitive subscale score improved by 4.1 points during the diet (P = .02) and reverted to baseline after the washout.
Conclusion

This pilot trial justifies KD studies in mild Alzheimer's disease.
Vabljeni na moje spletne strani: www.gaspergrom.com
PrejšnjaNaslednja

Vrni se na Ketogena dieta

Kdo je prisoten

Po forumu brska: 0 registriranih uporabnikov in 4 gostov


 
Brezplačna knjiga Fit do poletja Maxximum paket Biggest Winner Slovenija ZANJO
 
Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group.
.